Omeros Receives Grant For Addiction Treatment Research

Approximately 20 million Americans aged 12 or older admitted to illicit drug use in 2006, according to Drug-Addiction-Support.org. As substance abuse remains a consistent problem across the country, there is a growing demand for rehabilitation facilities and treatment centers. These programs can help addicts detoxify and make healthier lifestyle choices.

This week, Omeros announced that they will be receiving additional funding from the National Institute on Drug Abuse (NIDA). These grants will be used by the pharmaceutical company to conduct research on medications to help addicts quit drugs ranging from opiates to nicotine. Omeros is also working on creating peroxisome proliferator-activated receptor gamma agonists to prevent and treat compulsive behavioral conditions. The company will receive $3.6 million over the course of four years.

“We appreciate the continued support of NIDA and the New York State Psychiatric Institute in advancing the clinical development of this program,” said Omeros chief executive officer, Gregory Demopulos.

Nearly 10 million Americans admitted to driving under the influence of an illegal drug last year, according to Drug-Addiction-Support.org. Donations and grants can help researchers develop new treatments for the growing substance abuse epidemic.